Related Experiment Video
Updated: Mar 12, 2026
08:55
The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
17.3K
Cardiac Cachexia: Perspectives for Prevention and Treatment
Marina Politi Okoshi1, Rafael Verardino Capalbo1, Fernando G Romeiro1
1Departamento de Clínica Médica, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista, São Paulo, SP, Brazil.
Arquivos Brasileiros De Cardiologia
|November 5, 2016
Summary
Cachexia, a condition linked to heart failure, worsens patient outcomes. Management focuses on preserving muscle mass through nutrition and exercise.
Area of Science:
- Cardiology and Pathophysiology
- Metabolic Disorders and Muscle Wasting
Background:
- Cachexia is a common and serious condition in chronic heart failure patients.
- It independently predicts higher morbidity and mortality, regardless of other clinical factors.
- Skeletal muscle wasting is a key feature, often preceding cachexia and indicating a poor prognosis.
Purpose of the Study:
- To review the clinical impact and management strategies for cachexia in heart failure.
- To highlight the multifactorial nature and incomplete understanding of cachexia's mechanisms.
- To emphasize current approaches to prevention and treatment.
Main Methods:
- Literature review of cachexia in chronic heart failure.
- Analysis of clinical consequences, pathophysiological mechanisms, and treatment options.
- Focus on nonpharmacological interventions.
Main Results:
- Cachexia's consequences are tied to weight loss and systemic inflammation.
- Numerous treatment avenues exist, including nutritional support, neurohormonal blockade, and exercise.
- Nonpharmacological therapies are central to current management.
Conclusions:
- Cachexia significantly impacts heart failure prognosis and requires multifaceted management.
- Understanding the complex mechanisms is crucial for developing targeted therapies.
- Nutritional support and physical exercise are foundational for cachexia prevention and treatment.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
571
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
571
01:29Cardiomyopathy VI: Nursing Management
433
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
433
01:30Cardiomyopathy II: Dilated Cardiomyopathy
700
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
700
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
607
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
607
01:30Heart Failure VII: Nursing Interventions
629
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
629
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
714
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
714